ABT vs ITGR
ABT: A diversified global health care leader focused on diagnostic, medical device, nutritional, and pharmaceutical solutions. ITGR: Integer Holdings is a leading medical device outsource manufacturer supplying critical components and complex assemblies to global OEMs in the cardiac and neuromodulation sectors.
Side-by-side fundamentals
| Metric | ABT | ITGR | Edge |
|---|---|---|---|
| Price as of 2026-10-21 close | $100.51 | $126.70 | |
| Market cap | $173.9B | $4.3B | |
| P/E as of 2026-10-21 | 28.15 | 34.71 | ABT lower |
| PEG as of 2026-10-21, 3-year EPS CAGR to FY2025 | n/a | 2.62 | |
| Net margin FY2025, SEC XBRL | +14.7% | +5.5% | ABT higher |
| Gross margin FY2025, SEC XBRL | n/a | +27.0% | |
| Operating margin FY2025, SEC XBRL | +18.2% | +11.9% | ABT higher |
| ROE FY2025, SEC XBRL | +12.4% | +5.9% | ABT higher |
| ROA FY2025, SEC XBRL | +7.5% | +3.0% | ABT higher |
| Debt / equity | 0.65 | 0.72 | ABT lower |
| Revenue growth (YoY) FY2025, SEC XBRL | +5.7% | +8.0% | ITGR higher |
| Revenue CAGR (3y) SEC XBRL | +0.5% | +11.7% | ITGR higher |
| Dividend yield as of 2026-09-03 | +2.5% | n/a | |
| Dividend streak (yrs) SEC XBRL | 4 | 0 | ABT higher |
| Beta as of 2026-09-03 | 0.18 | 0.76 | |
| 1-year return as of 2026-10-21 close | -21.2% | +17.4% | ITGR higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.